Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine for Cognitive Aging in the Elderly
NCT00935493Phase 2Completed
- Sponsor
- Yale University
- Start
- Jun 2009
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of guanfacine in cognitive aging, sponsored by Yale University. Started Jun 2009; status: completed.
02
Drugs
guanfacine
03
Conditions
cognitive aging
Beyond the preview
Go deeper on NCT00935493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00935493.